# Requires health insurers to provide coverage for opioid antagonists and devices

**Bill ID:** A1393AA
**Session:** 2023
**Sponsor:** Linda Rosenthal
**Status:** In Assembly Committee
**PDF:** [A1393A PDF](https://legislation.nysenate.gov/pdf/bills/2023/A1393A)

## Summary

Requires health insurers to provide coverage for opioid antagonists and devices.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  1393--A
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  January 17, 2023
  ___________
 
 Introduced  by  M.  of  A.  L. ROSENTHAL,  SANTABARBARA -- read once and
  referred to the Committee on Insurance -- recommitted to the Committee
  on Insurance in accordance with Assembly Rule 3, sec. 2  --  committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee

 AN  ACT  to  amend  the  insurance  law, in relation to requiring health
  insurers to provide coverage for opioid antagonists and devices
 
  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
 amended by adding a new paragraph 39 to read as follows:
  (39) (A) (I) EVERY POLICY WHICH  PROVIDES  COVERAGE  FOR  PRESCRIPTION
 DRUGS  SHALL  INCLUDE  COVERAGE  FOR  AT LEAST ONE OPIOID ANTAGONIST AND
 DEVICE. PRIOR AUTHORIZATION MAY BE REQUIRED  FOR  NON-GENERIC  FORMS  OF
 OPIOID ANTAGONISTS AND DEVICES.
  (II)  AS USED IN THIS PARAGRAPH "OPIOID ANTAGONIST AND DEVICE" MEANS A
 DRUG APPROVED BY THE FOOD AND DRUG ADMINISTRATION  THAT,  WHEN  ADMINIS-
 TERED,  NEGATES  OR  NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
 EFFECTS OF AN OPIOID IN THE BODY. "OPIOID ANTAGONIST" SHALL  BE  LIMITED
 TO  NALOXONE  AND OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH
 FOR SUCH PURPOSE.
  (B) THE COVERAGE MANDATED  BY  THIS  PARAGRAPH  SHALL  INCLUDE  OPIOID
 ANTAGONISTS  PRESCRIBED OR DISPENSED VIA STANDING ORDER OR COLLABORATIVE
 PRACTICE AGREEMENT INTENDED FOR USE ON PATIENTS OTHER THAN THE INSURED.
  (C) A POLICY SHALL NOT IMPOSE A DEDUCTIBLE, CO-INSURANCE,  CO-PAYMENT,
 OR ANY OTHER COST-SHARING REQUIREMENT ON SUCH COVERAGE PROVIDED PURSUANT
 TO THIS PARAGRAPH.
  ยง 2. Subsection (l) of section 3221 of the insurance law is amended by
 adding a new paragraph 7-c to read as follows:
  (7-C)  (A)  (I)  EVERY POLICY WHICH PROVIDES COVERAGE FOR PRESCRIPTION
 DRUGS SHALL INCLUDE COVERAGE FOR AT  LEAST  ONE  OPIOID  ANTAGONIST  AND
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD01316-03-4
 A. 1393--A  2
 
 DEVICE.  PRIOR  AUTHORIZATION  MAY  BE REQUIRED FOR NON-GENERIC FORMS OF
 OPIOID ANTAGONISTS AND DEVICES.
  (II)  AS USED IN THIS PARAGRAPH "OPIOID ANTAGONIST AND DEVICE" MEANS A
 DRUG APPROVED BY THE FOOD AND DRUG ADMINISTRATION  THAT,  WHEN  ADMINIS-
 TERED,  NEGATES  OR  NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
 EFFECTS OF AN OPIOID IN THE BODY. "OPIOID ANTAGONIST" SHALL  BE  LIMITED
 TO  NALOXONE  AND OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH
 FOR SUCH PURPOSE.
  (B) THE COVERAGE MANDATED  BY  THIS  PARAGRAPH  SHALL  INCLUDE  OPIOID
 ANTAGONISTS  PRESCRIBED OR DISPENSED VIA STANDING ORDER OR COLLABORATIVE
 PRACTICE AGREEMENT INTENDED FOR USE ON PATIENTS OTHER THAN THE INSURED.
  (C) A GROUP OR BLANKET POLICY SUBJECT  TO  THIS  PARAGRAPH  SHALL  NOT
 IMPOSE A DEDUCTIBLE, CO-INSURANCE, CO-PAYMENT, OR ANY OTHER COST-SHARING
 REQUIREMENT ON SUCH COVERAGE PROVIDED PURSUANT TO THIS PARAGRAPH.
  ยง  3.  Section  4303  of  the insurance law is amended by adding a new
 subsection (vv) to read as follows:
  (VV) (1) (A) EVERY POLICY THAT IS ISSUED, AMENDED, RENEWED, EFFECTIVE,
 OR DELIVERED ON OR AFTER JANUARY FIRST,  TWO  THOUSAND  TWENTY-FIVE  AND
 PROVIDES  COVERAGE  FOR PRESCRIPTION DRUGS SHALL INCLUDE COVERAGE FOR AT
 LEAST ONE OPIOID ANTAGONIST  AND  DEVICE.  PRIOR  AUTHORIZATION  MAY  BE
 REQUIRED FOR NON-GENERIC FORMS OF OPIOID ANTAGONISTS AND DEVICES.
  (B)  AS USED IN THIS SUBSECTION "OPIOID ANTAGONIST AND DEVICE" MEANS A
 DRUG APPROVED BY THE FOOD AND DRUG ADMINISTRATION  THAT,  WHEN  ADMINIS-
 TERED,  NEGATES  OR  NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
 EFFECTS OF AN OPIOID IN THE BODY. "OPIOID ANTAGONIST" SHALL  BE  LIMITED
 TO  NALOXONE  AND OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH
 FOR SUCH PURPOSE.
  (2) A CONTRACT SUBJECT TO THIS SUBSECTION SHALL NOT IMPOSE  A  DEDUCT-
 IBLE,  COINSURANCE,  COPAYMENT, OR ANY OTHER COST-SHARING REQUIREMENT ON
 SUCH COVERAGE PROVIDED PURSUANT TO THIS SUBSECTION.
  ยง 4. This act shall take effect immediately and shall apply  to  poli-
 cies  and  contracts issued, renewed, modified, altered or amended on or
 after such effective date.